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Abstract: Staging criteria for renal cell carcinoma differ from many
other cancers, in that renal tumors are often spherical with subtle,
ﬁnger-like extensions into veins, renal sinus, or perinephric tissue.
We sought to study interobserver agreement in pathologic stage
categories for challenging cases. An online survey was circulated to
urologic pathologists interested in kidney tumors, yielding 89% re-
sponse (31/35). Most questions included 1 to 4 images, focusing on:
vascular and renal sinus invasion (n=24), perinephric invasion
(n=9), and gross pathology/specimen handling (n=17). Responses
were collapsed for analysis into positive and negative/equivocal for
upstaging. Consensus was regarded as an agreement of 67% (2/3) of
participants, which was reached in 20/33 (61%) evaluable scenarios
regarding renal sinus, perinephric, or vein invasion, of which 13/33
(39%) had ≥80% consensus. Lack of agreement was especially en-
countered regarding small tumor protrusions into a possible vascular
lumen, close to the tumor leading edge. For gross photographs, most
were interpreted as suspicious but requiring histologic conﬁrmation.
Most participants (61%) rarely used special stains to evaluate vas-
cular invasion, usually endothelial markers (81%). Most agreed that
a spherical mass bulging well beyond the kidney parenchyma into
the renal sinus (71%) or perinephric fat (90%) did not necessarily
indicate invasion. Interobserver agreement in pathologic staging
of renal cancer is relatively good among urologic pathologists
interested in kidney tumors, even when selecting cases that test
the earliest and borderline thresholds for extrarenal extension.
Disagreements remain, however, particularly for tumors with small,
ﬁnger-like protrusions, closely juxtaposed to the main mass.
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S taging of renal cell carcinoma differs somewhat fromthe prototypical cancer, in that expanding tumors do
not necessarily elicit desmoplastic or destructive in-
ﬁltrative response. Rather, renal cell carcinoma tumors are
largely rounded or spherical, with stage categories deﬁned
based on extension into the renal sinus, perinephric fat,
and renal veins.1,2 Speciﬁc ﬁndings indicating higher
pathologic pT stage are potentially more subtle than those
of tumors in other organs. Nonetheless, pathologic staging
may have substantial importance for determining clinical
follow-up schedules, patient counseling, and enrollment
in clinical trials for patients harboring higher-risk renal
cancers. In this study, we sought to assess the extent of
interobserver variability in assigning pathologic stage
variables in renal cell carcinoma, with emphasis on testing
the earliest and borderline thresholds for higher stage
categories.
METHODS
After approval of the study by the institutional review
board of the Henry Ford Health System, an online survey
was designed by 4 of the authors (S.R.W., P.R., M.B.A.,
and K.T.) to query pathologic stage scenarios in renal
cancer, using the SurveyMonkey platform (SurveyMonkey.
com, Palo Alto, CA) in an institutional HIPAA-secure
account. Thirty-ﬁve pathologists were invited to participate,
based on a perceived and demonstrated interest in tumors of
the kidney, with attempt to capture a broad geographic
distribution and including both senior and more recently
trained specialist urologic pathologists. Complete responses
were received from 31/35 invited (89%). Of the remaining 4,
1 responded but declined to participate, 1 did not complete
the entire survey, and 2 did not respond, all of which are
excluded from the following data. All participants agreed to
coauthor the resulting manuscript.
Most questions included 1 to 4 images, focusing on:
vascular and renal sinus invasion (n= 24), perinephric
invasion (n= 9), and gross pathology/specimen handling
(n= 17). For the purposes of analysis, the 33 questions
corresponding to renal sinus and perinephric invasion
could be studied for consensus interpretation, which was
deﬁned as 2/3 (67%) agreement in favor of or against
higher stage. Cases were also assessed for a strong con-
sensus, if ≥ 80% agreement in favor of or against a higher
stage category. Interpretations were collapsed into positive
for the higher stage category and negative or equivocal,
since there was often varied interpretation of renal sinus or
renal vein invasion, or both, yet all resulting in the same
pT3a stage category. Equivocal responses (suspicious but
not deﬁnitive for higher stage), were included in the neg-
ative category, considering the American Joint Commis-
sion on Cancer (AJCC) recommendations that equivocal
cases default to the lower of the 2 considerations.3 Ques-
tions focusing on gross pathology were largely not ame-
nable to assigning consensus diagnoses, as most responses
indicated that the ﬁndings were suspicious for invasion,
but that histologic conﬁrmation was required. Therefore,
these and other general questions were not counted in the
denominator for consensus. On the basis of knowledge
that tumor histologic subtypes have different growth
patterns, including variable extension beyond the tumor
pseudocapsule (more common in papillary renal cell
carcinoma)4 and that some benign neoplasms may have
intravascular growth,5–7 a set of questions also queried
whether the participants believe that staging parameters
may have different relevance based on tumor subtype.
RESULTS
Brief summaries of the focus and responses of each
question are included in Supplemental File 1 (Supplemental
Digital Content 1, http://links.lww.com/PAS/A634). Partici-
pants represented the United States (n=21), Canada (n=2),
Australia, Czech Republic, Italy, Japan, New Zealand,
Switzerland, Spain, and United Kingdom (1 each). Con-
sensus of 67% (2/3) was reached in 20/33 (61%) evaluable
scenarios regarding renal sinus, perinephric, or vein invasion,
of which 13/33 (39%) had >80% consensus. Challenging
cases for potential early vein branch invasion are shown in
Figure 1. In the context of a tumor outpouching or ﬁnger-like
protrusion possibly corresponding to a vein, interpretation
as pT3a increased when the possible venous structure
demonstrated a more robust lumen and when it was
juxtaposed to renal sinus fat (Fig. 2) or within renal sinus
(Fig. 3). Scenarios demonstrating direct soft tissue extension
into the renal sinus (questions 20 to 25 in Supplemental File
1, Supplemental Digital Content 1, http://links.lww.com/
PAS/A634, Figs. 4A, B) all reached consensus for renal sinus
invasion.
When queried as to the presence of a ﬁbromuscular rim
associated with potential intravascular tumor (Fig. 4C),
responses approached but did not reach consensus as to
whether this type of smooth muscle argues against vascular
invasion (35%) or does not affect the interpretation (65%),
that is, tumor can bring vein wall with it and still represent
vein invasion. Additional comments by participants indicated
that this would depend on the context and size of the
structure in question. When asked if a layer of such tissue
contains compressed normal structures, such as glomeruli or
nonneoplastic tubules, there was 97% agreement that this
argued against invasion.
One example of papillary renal cell carcinoma with a
few tubules extending into loose tissue at the perinephric
interface in the setting of possible previous biopsy artifact
was interpreted as not deﬁnitive for invasion (68%);
however, for the same case, responses shifted to consensus
agreement (74%) regarding pT3a stage, assuming there
had not been a prior biopsy. Regarding speciﬁc criteria
for interpreting histologic features as biopsy site artifact,
only 48% reported having speciﬁc criteria in this setting.
Free text responses included presence of hemosiderin or
hemorrhage (n= 9), conﬁrmed history of biopsy (n= 7),
and linear distribution of the tumor (n= 5). A minority of
participating responders indicated that they interpret fat
invasion differently for papillary renal cell carcinoma
(19%) compared with clear cell renal cell carcinoma, and
42% reported that they believe that staging parameters are
Williamson et al Am J Surg Pathol  Volume 42, Number 9, September 2018
1254 | www.ajsp.com Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
Copyright r 2018 Wolters Kluwer Health, Inc. All rights reserved.
less relevant to chromophobe renal cell carcinoma. How-
ever, only 3% indicated using different thresholds for
invasion chromophobe renal cell carcinoma (Fig. 4D).
For gross pathology images, the most common re-
sponse was that the ﬁndings were suspicious for upstaging
(48% to 68%) but that histologic conﬁrmation is required
(Fig. 5A). Therefore, these were excluded from considering a
consensus diagnosis, as the ambiguous category was the
most common response. When prompted that gross ﬁndings
are convincing for vein invasion, 58% of participants were
willing to interpret the tumor as pT3a, even if the histologic
sections did not clearly demonstrate a vascular lumen,
whereas 26% were not, and 16% gave and “other” response
listing additional strategies, including submitting additional
sections, preparing additional section levels, or using
additional stains to conﬁrm the vascular lumen.
Regarding interpretation of the vein margin, consensus
(68%) was that histologic conﬁrmation of tumor adherent to
the margin is required for diagnosis of a positive vein mar-
gin. When asked if intravascular tumor extends beyond the
vein margin, 3% interpreted this as always a positive margin,
6% considered it to depend on gross evaluation of attach-
ment, and 90% required microscopic conﬁrmation of at-
tachment to the vein wall. When shown a round tumor
bulging into the renal sinus (Fig. 5B) or perinephric fat
(Fig. 5C), there was a consensus that this did not necessarily
indicate invasion (71% and 90%, respectively, for renal sinus
and perinephric tissue). Microscopically, a relatively large
rounded nodule appearing possibly separate from the tumor
did not reach consensus for perinephric invasion (Fig. 5D).
Regarding a renal tumor composed of a large unilocular cyst
with a single nodule of solid tumor in 1 wall of the cyst, 71%
FIGURE 1. Challenging cases for potential early vein branch or renal sinus invasion: A, A selected image from question 3 dem-
onstrates a clear cell renal cell carcinoma tumor that abuts and indents a large vein at the hilum. This example had no consensus for
pT3a (52% yes, 48% no/equivocal). B, A selected image from question 5 demonstrates a clear cell renal cell carcinoma tumor that
extends beyond 1 fibromuscular plane (black line) but is separated from the hilar fat by a second fibromuscular plane (white line).
This example had no consensus for pT3a (42% yes, 58% no/equivocal). C and D, Two images from question 4 demonstrate a clear
cell renal cell carcinoma tumor with tumor nodules that extend into hilar vascular tissue with rounded to elongated finger-like
extension. This example had no definite consensus for pT3a (61% yes, 39% no/equivocal).
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would base the tumor size on the combined size of the cyst
and the tumor, only if the cyst has a lining similar to the
neoplastic cells in the solid component. The minority would
use the larger size (cyst+mass) regardless of the appearance
of the cyst lining (16%) or the smaller size, regardless of the
cyst lining (3%). The remaining 10% gave a write-in response
that they would note both sizes in a comment, of which two
would use the larger size and one did not specify.
Most participants only rarely used special stains for
diagnosis of vascular invasion (61%), which were reported
to most commonly be endothelial immunohistochemical
markers (81%), followed by muscle markers (35%), elastic
stain (27%), or trichrome stain (15%). Regarding the
phenomenon of retrograde venous invasion,8 48%
reported being comfortable with recognizing this ﬁnding,
and 26% document its presence in their reports, whereas
48% classify it as pT3a, but do not speciﬁcally document
it. The remaining found it difﬁcult to assess it in practice
(16%) or reported being not familiar with it (6%). Of note,
as multiple responses were allowed for this question, the
percentages do not sum to 100%.
The most recent, 8th edition of the AJCC staging
system has removed the previous requirements that renal
vein branch invasion be identiﬁed grossly and that the vein
must contain muscle to be considered as such.2 Most
participants reported that they had previously classiﬁed
cases without strictly using these criteria. For example,
when invasion was either not recognized grossly, or
the muscle was inconspicuous, the case was still staged
pT3a (84%). Conversely, 16% reported that this would
introduce a change in their practice, because they had
refrained from interpreting these as pT3a previously.
FIGURE 2. Challenging cases for potential intrarenal early vein branch invasion: A, A selected image from question 7 demonstrates
a clear cell renal cell carcinoma tumor with a finger-like extension that herniates beyond the fibromuscular pseudocapsule of the
tumor. This example had consensus against pT3a (6% yes, 94% no/equivocal). B and C, Selected images from question 10
demonstrate another finger-like extension away from the mass, but still within the kidney. In contrast to question 7, there is a focal
possible vascular lumen (C, arrows). This example had consensus against pT3a, but with a higher fraction of participants inter-
preting as vein invasion (29% yes, 71% no/equivocal). D, A selected image from question 12 demonstrates a clear cell renal cell
carcinoma tumor with a finger-like extension. This example includes a possible vein lumen (black arrow) and focal renal sinus fat
(white arrow). Interpretation shifted in favor of pT3a for this case but did not reach consensus (58% yes, 42% no/equivocal).
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When comparing pathologists in the United States
to those of other countries, there were 9 questions for
which the overall response for or against increased stage
was markedly different between groups (shown in Sup-
plemental File 1, Supplemental Digital Content 1, http://
links.lww.com/PAS/A634). However, a speciﬁc theme
could not be discerned regarding the nature of these cases.
In 6, the non-US pathologists were more strongly in favor
of a higher stage, whereas in 1, the US pathologists were
more strongly in favor of higher stage. In another, the US
pathologists were more uniformly against higher stage
(90%), whereas the non-US group was more equivocal
(40%/60%). For the question regarding the new AJCC
criteria for vein involvement, the US pathologists
predominantly indicated that they were already using
the updated criteria (95%) more than the non-US
pathologists (60%).
DISCUSSION
The criteria for staging and invasion (vascular, per-
inephric fat, renal sinus) of kidney tumors have been
previously addressed by the urologic pathology com-
munity at the 2012 International Society of Urological
Pathology Consensus (ISUP) Consensus Conference and
speciﬁc recommendations were issued regarding handling
and staging of renal cell carcinoma.1 Therefore, this sur-
vey represents the ﬁrst major attempt to evaluate the ap-
plication of speciﬁc staging criteria in nonstraightforward
scenarios, or scenarios which have not been previously
covered by speciﬁc guidelines, in a geographically diverse
population of urologic pathologists.
Renal cell carcinomas represent a group of tumors
that often manifest invasion with rounded tumor out-
pouchings and extension into vascular structures, carrying
an intact endothelial cell layer.9 Therefore, the criteria for
FIGURE 3. Cases with high agreement for pT3a. A and B, Selected images from question 16 demonstrate a clear cell renal cell
carcinoma tumor with a polypoid nodule loosely connected within a vascular space (A, circled). Higher magnification reveals the
paired artery (a) and tumor nodule within accompanying vein. This example reached consensus in favor of pT3a (84% yes, 16%
no/equivocal). C and D, Selected images from question 11 demonstrate a clear cell renal cell carcinoma tumor with a polypoid
nodule protruding into a renal sinus vein (A, arrow and B). This example reached consensus in favor of pT3a (94% yes, 6% no/
equivocal).
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assessing invasion are potentially different from the proto-
typical cancer (crab-like), with inﬁltrative growth and des-
moplastic reaction. In this study we aimed to evaluate
whether urologic pathologists use similar thresholds for in-
vasion, especially in cases that test the earliest or borderline
thresholds for increasing the pathologic stage categories.
We found that overall agreement for or against pT3a is
relatively good among the urologic pathologists interested in
kidney cancer, with a substantial number of cases (20/33
speciﬁc evaluable scenarios) reaching two thirds consensus
(67%). Of these, 13 had a strong consensus of >80%
(Table 1). Still some scenarios exist that did not reach
complete agreement in our cohort, especially when the tumor
extension into a putative vein branch remains within the
kidney parenchyma, and when there is unclear evidence of
the vein lumen (Figs. 1, 2). When tumor is in direct contact
with the renal sinus fat, agreement was good (Fig. 4).
This study provides some potential guidance (based
on subspecialty opinion) for a few areas of uncertainty that,
to our knowledge, have not been speciﬁcally addressed in
the previous staging recommendations. Consensus was ap-
proached but not reached as to whether a smooth muscle
layer at the edge of the intravascular tumor is compatible
with venous invasion (65%). That is, can a tumor bring part
of the smooth muscle of the vein wall with it, yet still be
invasive? Despite not reaching a consensus, resolving this
in practice may be facilitated by other strategies, such as
critically reassessing the gross appearance or evaluating
additional section levels or special stains. These may in-
crease pathologists’ conﬁdence (or lack thereof) that such
FIGURE 4. Scenarios for direct renal sinus invasion and other situations: A and B, The 2 images provided to participants from
question 22 show tumor cells from a clear cell renal cell carcinoma extending into renal sinus fat. This example reached consensus
for pT3a (97% yes, 3% no/equivocal). C, A representative image from question 26 shows a possible intravascular tumor with a
layer of smooth muscle tissue at the edge (arrow). This question approached but did not reach consensus as to whether this type
of smooth muscle argues against vascular invasion (35%) or does not affect the interpretation (tumor can bring vein wall with it
and still represent vein invasion, 65%). D, This selected image from question 28 shows eosinophilic chromophobe renal
cell carcinoma with multinodular growth bulging into perinephric fat (arrows). This question did not reach consensus for pT3a
(61% yes, 39% no/equivocal).
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outpouchings indeed represent venous extensions. In con-
trast, there was strong agreement (97%) that if this rim of
tissue contains normal structures, such as tubules or glo-
meruli, that it does argue against invasion. Another scenario
evaluated was the occurrence of a solid mass in the wall of
an apparently unilocular cyst. In this setting, using the cyst
size as the tumor size might increase the pathologic T stage
category within pT1 or pT2 category, whereas using the
solid component only might lower the pT category. This
situation reached consensus (71%) that the combined cyst
and mass size can be used, if the cyst appears to have a
similar neoplastic lining, whereas only the solid mass size
may be used if the cyst has denuded or different lining.
Regarding gross pathology, the balance of the survey
results indicates that most urologic pathologists require
microscopic conﬁrmation of gross ﬁndings for increasing
the stage, at least in the subtle and ambiguous cases that
were tested in this survey. This included gross images of
possible venous invasion, and queries regarding assessment
of the vein margin. However, 58% of participants reported
that they would be willing to report pT3a for a grossly
convincing example of vein invasion that lacks a clear his-
tologic lumen. Most agreed that the deﬁnition of a positive
vein margin necessitates that the tumor is microscopically
adherent to, or invading the vein wall at, the margin (ie,
gross presence of tumor at or beyond the resected end of the
vein is insufﬁcient for positive margin).
Another peculiar feature of renal cell carcinoma is
that tumors can bulge well beyond the normal contour of
the kidney and can sometimes be encapsulated by a layer of
normal or atrophic kidney tissue, which argues against in-
vasion. There was strong agreement (90%) that a spherical
mass bulging well into the perinephric tissue did not
necessarily constitute perinephric extension; however, this
decreased to 71% for a mass that bulged into the renal sinus,
perhaps due to the known proclivity of clear cell renal cell
FIGURE 5. Scenarios in gross pathology and extrarenal spread: A, A gross image from question 38 demonstrates outpouchings of
clear cell renal cell carcinoma into renal sinus and vascular tissue (arrows). Most participants responded that this was suspicious for
vascular invasion (68%) but that histologic confirmation is required. A minority (19%) reported that this was unequivocal for vein
invasion based on the gross features alone. B, For a round tumor bulging into the renal sinus, 71% of participants indicated that
this was not sufficient to assign pT3a. C, For a round tumor bulging into the perinephric fat, 90% of participants indicated that this
was not sufficient to assign pT3a. D, Histologically, a rounded nodule beyond the apparent renal capsule did not reach consensus
for pT3a (55% yes, 45% no/equivocal).
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carcinoma to invade the renal sinus10–12 and the need for
careful assessment of the possible invasion in this context.
When comparing US pathologists to non-US path-
ologists, there were 9 questions with marked differences;
however, it is uncertain if this reﬂects any truly signiﬁcant
practice patterns. One might consider whether a poten-
tially more litigious environment could inﬂuence diag-
nostic interpretations; however, due to the smaller subsets
of pathologists for comparison (including only 10 non-
US), even a small shift of 2 or 3 votes could make a rel-
atively large impact in the overall percentage.
A limitation of this study, and of any study that
uses the method of consensus specialist opinion, is that it
does not assess the true biological behavior of the depicted
cases. The main objective of the current study was to assess
whether urologic pathologists have similar interpretations of
speciﬁc criteria, to attempt to determine their reproducibility
across a spectrum of practices. Our aim was not to assess
whether the depicted foci of potential early invasion are
equally prognostic as those that demonstrate unequivocal
invasion. Nonetheless, practicing with substantial vigilance
for detecting early invasion is important for patient prog-
nosis, including recognition of early renal sinus or vascular
invasion, and potentially discriminating the level of renal
vein or vein branch extension.13–16 One study recently
demonstrated that main renal vein invasion is independently
associated with worse recurrence-free survival and cancer-
speciﬁc survival, when compared with segmental renal vein
branch invasion.15 This study, performed at a single in-
stitution, used reporting of general surgical pathologists,
with daily availability of consultations with urologic path-
ology specialists. There was additional review by a single
pathologist for equivocal cases. This study, however, did not
clarify how the earliest state of vein branch invasion was
deﬁned.15 Another study found that in patients with renal
cancer originally diagnosed as pT1, yet who died of renal
cancer, there was a substantial rate of undiagnosed vascular
or renal sinus invasion upon additional sampling, compared
with a control group of patients who did not die of pT1
renal cancer.16 Therefore, it appears that it is important to
carefully assess for early invasion. Such parameters likely
also have substantial relevance to clinical follow-up sched-
ules and possibly enrollment in clinical trials. Yet, apart
from the current study, the data are scant concerning in-
terobserver reproducibility and deﬁnitions of criteria for the
earliest ﬁndings of invasion. We believe that highlighting
these interpretations, combined with the study illustrations,
may aid practicing pathologists in evaluating challenging
cases. Although the low-magniﬁcation images provided
(captured from whole slide images in most cases) in this
study would be helpful for assessing the microscopic con-
text, the format of providing 1 to 4 still images is different
from the surgical pathology practice. Some participants in-
dicated that in practice, they would further evaluate cases
with additional gross sampling, additional histologic levels,
or special stains.
Some recommendations that emerge from this work
include speciﬁc scenarios where the general surgical patholo-
gist may regard high conﬁdence for or against extrarenal in-
vasion, as summarized in Table 1. Particularly, these include
tumors with ﬁnger-like extensions that lie within probable or
deﬁnite vascular spaces, adjacent to or within the renal sinus
fat, “satellite” nodules within the renal sinus fat, and tumor
that intermingles with the renal sinus fat, either in a jagged
conﬁguration or with distinct nodules or herniation that is in
the plane of fat. Scenarios that were considered not extrarenal
spread included ﬁnger-like protrusions that remained within
the kidney (without deﬁnite vascular lumen or adjacent
fat, which may represent lack of continuity of the tumor
pseudocapsule rather than invasion of an anatomic
structure),4 discrete nodules within the tumor pseudocapsule
or renal capsule, and rounded bulge into the perinephric fat.
In equivocal scenarios, we recommend a combination of
reassessing the gross specimen and, if appropriate, correlation
with imaging studies, consideration of recut levels of the tissue
block, with or without special stains or immunohisto-
chemistry, as relevant to the diagnostic question.
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